ARTICLE | Financial News
After announced merger, TapImmune raises $70M
June 15, 2018 7:59 PM UTC
TapImmune (NASDAQ:TPIV) jumped $3.05 (51%) to $9 June 8 after it priced a $70 million private placement led by new investor New Enterprise Associates. The company is selling 17.5 million shares at $4. New investors Aisling Capital and Perceptive Advisors also participated as did other undisclosed new and existing investors.
The price is a 33% discount to TapImmune's June 7 close of $5.95. Investors will also receive five-year warrants to purchase 13.1 million shares at $5...